| EPIGENOMICS AG NA O.N. |
| Deutschland |
| Gesundheit |
| DE000A37FT41 / A37FT4 |
| ECX (Frankfurt) |
| FRA:ECX, ETR:ECX, ECX:GR |
| - |
| https://www.epigenomics.c.. |
|
Epigenomics AG is a molecular diagnostics company focused on transforming cancer testing through advanced blood-based technologies. Headquartered in Berlin, Germany, the company specializes in developing and globally commercializing innovative biomar..
>Volltext.. |
| 0.76 Mio. EUR |
| 0.35 Mio. EUR |
| 0.02 Mio. EUR |
| - |
| -0.31 Mio. EUR |
| -0.35 EUR |
| - |
| 0.42 Mio. EUR |
| - |
| - |
| - |
| 91.05% |
| - |
| - |
| - |
| - |
| EPIGENOMICS |
| 05.04.26 |
|